EPZM — EPIZYME INC
EPZM (EPIZYME INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 30 funds have reported positions historically, with the sum of their latest reported stakes valued at $31.36M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q2 2022 | 7.54M | $11.08M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2022 | 2.63M | $3.87M | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2022 | 2.50M | $2.88M | 0.01% | New |
| D. E. Shaw & Co history | Q2 2022 | 1.73M | $2.54M | 0.00% | Reduce |
| Millennium Management history | Q2 2022 | 1.55M | $2.28M | 0.00% | Reduce |
| Geode Capital Management history | Q2 2022 | 1.52M | $2.23M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2022 | 836.96K | $1.23M | 0.00% | Add |
| Citadel Advisors history | Q2 2022 | 761.56K | $1.12M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2022 | 686.97K | $1.01M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2022 | 461.24K | $678.00K | 0.00% | Add |
| Renaissance Technologies history | Q2 2022 | 393.00K | $578.00K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2022 | 270.92K | $398.00K | 0.00% | Reduce |
| Prudential Financial history | Q1 2022 | 230.79K | $265.00K | 0.00% | Add |
| Deutsche Bank AG history | Q1 2022 | 178.41K | $206.00K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2022 | 128.23K | $188.00K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2022 | 86.48K | $127.00K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2022 | 69.20K | $102.00K | 0.00% | Add |
| UBS Group AG history | Q2 2022 | 66.51K | $98.00K | 0.00% | Add |
| Manulife Financial history | Q1 2022 | 64.90K | $75.00K | 0.00% | Add |
| BNY Mellon history | Q2 2022 | 46.53K | $68.00K | 0.00% | Reduce |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 |
|---|---|---|---|---|---|---|
| Vanguard Group | 7.83M | 7.90M | 7.86M | 5.98M | 7.45M | 7.54M |
| Goldman Sachs Group | — | — | 572.11K | 3.26M | 5.74M | 2.63M |
| D. E. Shaw & Co | — | — | — | 259.52K | 2.32M | 1.73M |
| Millennium Management | — | — | 421.93K | 1.95M | 6.22M | 1.55M |
| Geode Capital Management | — | — | 1.69M | 1.66M | 2.38M | 1.52M |
| Morgan Stanley | — | — | 2.71M | 788.36K | 818.39K | 836.96K |
| Citadel Advisors | — | — | 104.25K | 832.63K | 4.26M | 761.56K |
| Charles Schwab Investment Management | — | — | 629.08K | 637.48K | 1.02M | 686.97K |
| Citigroup Inc | — | — | 230.89K | 28.26K | 21.33K | 461.24K |
| Renaissance Technologies | — | — | — | 509.19K | 671.79K | 393.00K |
| Northern Trust Corp | — | — | 936.26K | 948.55K | 1.37M | 270.92K |
| T. Rowe Price Associates | — | — | 94.16K | 57.26K | 141.10K | 128.23K |
| AQR Capital Management | — | — | — | 18.24K | 457.67K | 86.48K |
| Legal & General Investment Management America | — | — | 62.77K | 62.77K | 53.91K | 69.20K |
| UBS Group AG | — | — | 40.40K | 1.50K | 1.50K | 66.51K |
| BNY Mellon | — | — | 303.76K | 320.18K | 424.78K | 46.53K |
| Two Sigma Investments | — | — | 12.00K | 1.02M | 1.12M | 45.32K |
| Fidelity Management & Research (FMR) | — | — | 1.80M | 865.37K | 2.62M | 18.19K |
| JPMorgan Chase & Co | — | — | 271.42K | 206.77K | 246.91K | 5.00K |
| Wells Fargo & Co | — | — | 119 | 43.25K | 25.41K | 1.01K |